Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Quest Diagnostics's Enterprise Value is $25,074 Mil.
Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $1,434 Mil. Therefore, Quest Diagnostics's EV-to-EBIT ratio for today is 17.49.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Quest Diagnostics's Enterprise Value is $25,074 Mil.
Quest Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $1,951 Mil. Therefore, Quest Diagnostics's EV-to-EBITDA ratio for today is 12.85.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Quest Diagnostics's Enterprise Value is $25,074 Mil.
Quest Diagnostics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $10,158 Mil. Therefore, Quest Diagnostics's EV-to-Revenue ratio for today is 2.47.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Quest Diagnostics Enterprise Value Historical Data
The historical data trend for Quest Diagnostics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Quest Diagnostics's Enterprise Value
For the Diagnostics & Research subindustry, Quest Diagnostics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Diagnostics's Enterprise Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Quest Diagnostics's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Quest Diagnostics's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Diagnostics (NYSE:DGX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Quest Diagnostics's current Enterprise Value is $25,074 Mil.
Quest Diagnostics's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,434 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Quest Diagnostics's current Enterprise Value is $25,074 Mil.
Quest Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,951 Mil.
Quest Diagnostics's current Enterprise Value is $25,074 Mil.
Quest Diagnostics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $10,158 Mil.
Quest Diagnostics's current Enterprise Value is $25,074 Mil.
Quest Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,056 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Diagnostics Enterprise Value Related Terms
Thank you for viewing the detailed overview of Quest Diagnostics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DGX has been successfully added to your 